Brian Christopher Betts

8PUBLICATIONS
36CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 08, 2024
Novel Scoring System for Ranking Hematopoietic Stem Cell Transplantation.

Lee Ann Baxter-Lowe, Tao Wang, Michelle Kuxhausen

|Jul 24, 2024
JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results.

Joseph Pidala, Shernan G Holtan, Kelly Walton

|Jan 09, 2023
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality.

Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton

|Oct 20, 2021
Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repair.

Kelly Walton, Kirsti Walker, Megan Riddle

|Jun 14, 2018
Hepatic veno-occlusive disease following sirolimus-based immune suppression.

Farhad Khimani, George B McDonald, Howard M Shulman

|Apr 20, 2018
Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease.

Lia Perez, Hugo Fernandez, Pedro Horna

Pageof 2

Frequent Collaborators

3 joint publications

Marco L Davila

2 joint publications

Taiga Nishihori

2 joint publications

Shernan G Holtan

2 joint publications

Kelly Walton